-
601
Construction and characterization of chimeric FcγR T cells for universal T cell therapy
Published 2025-01-01Subjects: Get full text
Article -
602
Intracapillary Monoclonal IgM Deposition Concomitant With Cold Agglutinin Disease
Published 2025-03-01Subjects: Get full text
Article -
603
Immunomodulatory Effects of Hemagglutinin- (HA-) Modified A20 B-Cell Lymphoma Expanded as a Brain Tumor on Adoptively Transferred HA-Specific CD4+ T Cells
Published 2014-01-01“…Previously, the mouse A20 B-cell lymphoma engineered to express hemagglutinin (HA) antigen (A20HA) was used as a systemic tumor model. …”
Get full text
Article -
604
Clinical trial participation, clinical care, and patient outcomes by practice setting: a real-world database analysis of patients with Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma
Published 2025-12-01“…Objective This study was designed to compare treatment patterns, clinical trial participation, and clinical outcomes among patients with small lymphocytic lymphoma/chronic lymphocytic leukemia (CLL) or Mantle cell lymphoma (MCL) by site of care.Methods A nationwide electronic health record (EHR)-derived de-identified database was utilized for this study. …”
Get full text
Article -
605
-
606
Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma
Published 2021-01-01“…Epstein-Barr virus-latent membrane protein 1 (EBV-LMP1) was associated with lymphoma, but its specific mechanism is still controversial. …”
Get full text
Article -
607
Early Serum Heme Oxygenase-1, Soluble Vascular Endothelial Growth Factor Receptor-1, and B-Cell Lymphoma/Leukemia-2 Levels and Unfavorable Obstetric Outcomes
Published 2022-08-01Subjects: “…B-cell lymphoma/leukemia-2…”
Get full text
Article -
608
NCAPD3 promotes diffuse large B-cell lymphoma progression through modulating SIRT1 expression in an H3K9 monomethylation-dependent manner
Published 2025-02-01Subjects: “…Diffuse large B-cell lymphoma…”
Get full text
Article -
609
Chemotherapy-induced cellular senescence promotes stemness of aggressive B-cell non-Hodgkin’s lymphoma via CCR7/ARHGAP18/IKBα signaling activation
Published 2025-01-01“…Background Resistance to existing therapies is a major cause of treatment failure in patients with refractory and relapsed B-cell non-Hodgkin’s lymphoma (r/r B-NHL). Therapy-induced senescence (TIS) is one of the most important mechanisms of drug resistance.Methods This study used single-cell RNA sequencing to analyze doxorubicin-induced senescent B-NHL cells. …”
Get full text
Article -
610
Case report: From misdiagnosis to timely detection: a clinical and imaging guide to neurological presentations of diffuse large B-cell lymphoma—insights from six cases
Published 2025-02-01“…BackgroundThe clinical spectrum of diffuse large B-cell lymphoma (DLBCL) is notably heterogeneous. Some DLBCL patients initially present with neurological manifestations, leading to their preliminary diagnosis within neurology departments. …”
Get full text
Article -
611
A Case Series of Diagnostic Challenges in Mycosis Fungoides in Resource-poor Settings: Blood Film Examination – A Useful Tool
Published 2024-12-01Subjects: Get full text
Article -
612
Risk Stratification and Adjuvant Chemotherapy for High‐Risk Stage IA Lung Adenocarcinoma: The Unmet Needs
Published 2025-01-01Subjects: Get full text
Article -
613
Lymphomatoid Papulosis Type E With T-Cell Receptor Gamma Positivity
Published 2025-01-01Subjects: Get full text
Article -
614
APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway
Published 2025-01-01Subjects: “…Diffuse large B-cell lymphoma…”
Get full text
Article -
615
Refining prognostic assessment of diffuse large B-cell lymphoma: insights from multi-omics and single-cell analysis unveil SRM as a key target for regulating immunotherapy
Published 2025-01-01“…HPSI shared malignant proliferative phenotype resembling Burkitt lymphoma. Genomic analysis revealed extensive copy-number loss in the chemokine and interleukin coding regions within HPSI. …”
Get full text
Article -
616
Advanced NGS analysis of cell-free tumor DNA supports clonal relation to primary high-grade B-cell lymphoma lesion and CNS relapse despite MRI negativity
Published 2025-02-01Subjects: “…High-grade B-cell lymphoma…”
Get full text
Article -
617
Exploring the enigmatic influence of miR-155 in oral squamous cell carcinoma: An odyssey from molecular maneuvers to therapeutic prospects
Published 2024-06-01Subjects: “…Dysregulation of B-Cell Lymphoma-6 (BCL-6)…”
Get full text
Article -
618
Assessment of the Diagnostic and Prognostic Values of CD200 and CD43 in CLL and Leukemic Phase of NHL
Published 2024-12-01Subjects: Get full text
Article -
619
Characteristics and outcomes of secondary acute lymphoblastic leukemia (sALL) after multiple myeloma (MM): SEER data analysis in a single-center institution
Published 2025-01-01Subjects: “…Precursor cell lymphoblastic leukemia-lymphoma…”
Get full text
Article -
620
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab
Published 2025-12-01Subjects: “…Cutaneous T-cell lymphoma…”
Get full text
Article